Eli Lilly pushes for NHS drug price increases in return for its UK investment
US pharmaceutical group ‘optimistic’ about reaching deal with British government
Related reading
Eli Lilly not yet ready to unfreeze UK investments, says pharma boss
US drugmaker wants changes to types of drugs approved in Britain
Eli Lilly boss brands UK ‘worst country in Europe’ for cheap drug prices
Dave Ricks says Britain will miss out on medicines and future investment unless it pays more
NHS to increase medicines spending to avoid threatened Trump tariffs
UK government will make it easier for drugs to be approved for use in order to secure carve-out from import levies
UK urges pharma companies to invest after reaching drug pricing deal with US
Accord will result in higher medicines spending in Britain in exchange for exemption from threatened Trump tariffs
Britain is squeezing AstraZeneca too tight
NHS curbs on drug prices have alienated UK pharma companies and become self-defeating
Eli Lilly becomes first pharma group to join $1tn club
Shares have soared more than 40% this year over strong demand for weight-loss and diabetes drugs